Image 1
Tolterodine Tartrate Tablet, Film Coated
Product Images NDC 0093-0010
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 0093-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a description of medication packaging. It contains information about the dosage, storage instructions, and manufacturing details of a tablet containing 1mg tolterodine tartrate. The packaging also includes a warning to keep the medication out of reach of children. The medication is manufactured in India and has a specific code number for tracking purposes. The provided barcode, GTIN (Global Trade Item Number), can be used for product identification.*
Image 3
Each tablet of this medication contains 2mg of tolterodine tartrate. The usual dosage and other important information can be found in the package insert. This medication should be stored between 20°C to 25°C (68°F to 77°F) and should be kept out of reach of children in a light container with a child-resistant closure. The medication is manufactured by Cipla Ltd. in Goa, India. The code number is GO/DRUGS/536 and the batch was manufactured in April 2015 with a revision number of B4/2015.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
